Lack of effect of gold therapy on abnormal IgG and IgM metabolism in rheumatoid arthritis

Abstract
Turnover studies with radioactive iodine‐labeled immunoglobulins (125IgG and 131IgM) and standard clinical tests were performed in 8 patients with rheumatoid arthritis before and after 2–5 months treatment with sodium‐aurothiosulphate (Sanocrysine®). Seven untreated patients served as controls. Fractional rates of catabolism and rates of synthesis of IgG and IgM were increased in all patients. After gold treatment there was a nonsignificant decrease in IgG metabolic variables, whereas IgM variables remained unchanged. The reduction in immunoglobulin metabolism correlated with clinical and serologic activity in only 1 of the 8 cases.